Embecta Corp Net Income
| EMBC Stock | USD 10.47 0.88 7.75% |
As of the 5th of February, Embecta Corp shows the Mean Deviation of 2.03, coefficient of variation of (1,279), and Standard Deviation of 2.82. Embecta Corp technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.
Embecta Corp Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 1.7131 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Income From Continuing Ops | 85.9 M | 81.6 M | |
| Net Income Applicable To Common Shares | 201.2 M | 299.7 M | |
| Net Income | 85.9 M | 81.6 M | |
| Net Income Per Share | 1.88 | 1.79 | |
| Net Income Per E B T | 0.63 | 0.75 |
Embecta | Net Income | Build AI portfolio with Embecta Stock |
Analyzing Embecta Corp's Net Income over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Income has evolved provides context for assessing Embecta Corp's current valuation and future prospects.
Latest Embecta Corp's Net Income Growth Pattern
Below is the plot of the Net Income of Embecta Corp over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Embecta Corp financial statement analysis. It represents the amount of money remaining after all of Embecta Corp operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Embecta Corp's Net Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Embecta Corp's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 95.4 M | 10 Years Trend |
|
Net Income |
| Timeline |
Embecta Net Income Regression Statistics
| Arithmetic Mean | 315,619,235 | |
| Geometric Mean | 254,059,076 | |
| Coefficient Of Variation | 51.65 | |
| Mean Deviation | 148,069,225 | |
| Median | 432,000,000 | |
| Standard Deviation | 163,030,587 | |
| Sample Variance | 26579T | |
| Range | 361.6M | |
| R-Value | (0.84) | |
| Mean Square Error | 8128T | |
| R-Squared | 0.71 | |
| Significance | 0.00002 | |
| Slope | (27,267,020) | |
| Total Sum of Squares | 425263.6T |
Embecta Net Income History
Other Fundumenentals of Embecta Corp
| Net Income From Continuing Ops | ||
| Net Income Applicable To Common Shares | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Embecta Corp Net Income component correlations
Embecta Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Embecta Corp is extremely important. It helps to project a fair market value of Embecta Stock properly, considering its historical fundamentals such as Net Income. Since Embecta Corp's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Embecta Corp's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Embecta Corp's interrelated accounts and indicators.
Click cells to compare fundamentals
Will Health Care Equipment & Supplies sector continue expanding? Could Embecta diversify its offerings? Factors like these will boost the valuation of Embecta Corp. Projected growth potential of Embecta fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Embecta Corp data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 0.827 | Dividend Share 0.6 | Earnings Share 1.69 | Revenue Per Share | Quarterly Revenue Growth (0.08) |
Embecta Corp's market price often diverges from its book value, the accounting figure shown on Embecta's balance sheet. Smart investors calculate Embecta Corp's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Embecta Corp's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Embecta Corp's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Embecta Corp should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Embecta Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Embecta Corp 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Embecta Corp's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Embecta Corp.
| 11/07/2025 |
| 02/05/2026 |
If you would invest 0.00 in Embecta Corp on November 7, 2025 and sell it all today you would earn a total of 0.00 from holding Embecta Corp or generate 0.0% return on investment in Embecta Corp over 90 days. Embecta Corp is related to or competes with CareDx, SIGA Technologies, Emergent Biosolutions, Aquestive Therapeutics, Myriad Genetics, Vir Biotechnology, and Evolent Health. Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbei... More
Embecta Corp Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Embecta Corp's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Embecta Corp upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.10) | |||
| Maximum Drawdown | 16.06 | |||
| Value At Risk | (5.47) | |||
| Potential Upside | 4.03 |
Embecta Corp Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Embecta Corp's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Embecta Corp's standard deviation. In reality, there are many statistical measures that can use Embecta Corp historical prices to predict the future Embecta Corp's volatility.| Risk Adjusted Performance | (0.05) | |||
| Jensen Alpha | (0.30) | |||
| Total Risk Alpha | (0.44) | |||
| Treynor Ratio | (0.19) |
Embecta Corp February 5, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.05) | |||
| Market Risk Adjusted Performance | (0.18) | |||
| Mean Deviation | 2.03 | |||
| Coefficient Of Variation | (1,279) | |||
| Standard Deviation | 2.82 | |||
| Variance | 7.96 | |||
| Information Ratio | (0.10) | |||
| Jensen Alpha | (0.30) | |||
| Total Risk Alpha | (0.44) | |||
| Treynor Ratio | (0.19) | |||
| Maximum Drawdown | 16.06 | |||
| Value At Risk | (5.47) | |||
| Potential Upside | 4.03 | |||
| Skewness | (0.57) | |||
| Kurtosis | 1.92 |
Embecta Corp Backtested Returns
Embecta Corp secures Sharpe Ratio (or Efficiency) of -0.13, which denotes the company had a -0.13 % return per unit of standard deviation over the last 3 months. Embecta Corp exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Embecta Corp's Coefficient Of Variation of (1,279), standard deviation of 2.82, and Mean Deviation of 2.03 to check the risk estimate we provide. The firm shows a Beta (market volatility) of 1.2, which means a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Embecta Corp will likely underperform. At this point, Embecta Corp has a negative expected return of -0.38%. Please make sure to confirm Embecta Corp's mean deviation, jensen alpha, potential upside, as well as the relationship between the standard deviation and treynor ratio , to decide if Embecta Corp performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.42 |
Average predictability
Embecta Corp has average predictability. Overlapping area represents the amount of predictability between Embecta Corp time series from 7th of November 2025 to 22nd of December 2025 and 22nd of December 2025 to 5th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Embecta Corp price movement. The serial correlation of 0.42 indicates that just about 42.0% of current Embecta Corp price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.42 | |
| Spearman Rank Test | 0.19 | |
| Residual Average | 0.0 | |
| Price Variance | 0.67 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Embecta Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Embecta Corp reported net income of 95.4 M. This is 72.05% lower than that of the Health Care Equipment & Supplies sector and significantly higher than that of the Health Care industry. The net income for all United States stocks is 83.29% higher than that of the company.
Embecta Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Embecta Corp's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Embecta Corp could also be used in its relative valuation, which is a method of valuing Embecta Corp by comparing valuation metrics of similar companies.Embecta Corp is currently under evaluation in net income category among its peers.
Embecta Corp ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Embecta Corp's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Embecta Corp's managers, analysts, and investors.Environmental | Governance | Social |
Embecta Corp Institutional Holders
Institutional Holdings refers to the ownership stake in Embecta Corp that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of Embecta Corp's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Embecta Corp's value.| Shares | Morgan Stanley - Brokerage Accounts | 2025-06-30 | 1.2 M | Rubric Capital Management Lp | 2025-06-30 | 1 M | Charles Schwab Investment Management Inc | 2025-06-30 | 886.3 K | Ameriprise Financial Inc | 2025-06-30 | 709.8 K | Dimensional Fund Advisors, Inc. | 2025-06-30 | 708.3 K | Northern Trust Corp | 2025-06-30 | 645.1 K | Bank Of New York Mellon Corp | 2025-06-30 | 635.8 K | D. E. Shaw & Co Lp | 2025-06-30 | 618.8 K | Goldman Sachs Group Inc | 2025-06-30 | 471.4 K | Blackrock Inc | 2025-06-30 | 8.9 M | Vanguard Group Inc | 2025-06-30 | 5.5 M |
Embecta Fundamentals
| Return On Asset | 0.17 | ||||
| Profit Margin | 0.09 % | ||||
| Operating Margin | 0.25 % | ||||
| Current Valuation | 1.85 B | ||||
| Shares Outstanding | 59.21 M | ||||
| Shares Owned By Insiders | 1.46 % | ||||
| Shares Owned By Institutions | 99.70 % | ||||
| Number Of Shares Shorted | 3.83 M | ||||
| Price To Earning | 4.91 X | ||||
| Price To Book | 2.61 X | ||||
| Price To Sales | 0.62 X | ||||
| Revenue | 1.08 B | ||||
| Gross Profit | 683.6 M | ||||
| EBITDA | 294.7 M | ||||
| Net Income | 95.4 M | ||||
| Cash And Equivalents | 292.3 M | ||||
| Cash Per Share | 5.05 X | ||||
| Total Debt | 1.43 B | ||||
| Current Ratio | 2.54 X | ||||
| Book Value Per Share | (11.12) X | ||||
| Cash Flow From Operations | 191.7 M | ||||
| Short Ratio | 6.45 X | ||||
| Earnings Per Share | 1.69 X | ||||
| Target Price | 16.67 | ||||
| Number Of Employees | 1.85 K | ||||
| Beta | 1.07 | ||||
| Market Capitalization | 672.06 M | ||||
| Total Asset | 28.3 M | ||||
| Retained Earnings | (445.6 M) | ||||
| Working Capital | 369.9 M | ||||
| Annual Yield | 0.06 % | ||||
| Net Asset | 28.3 M | ||||
| Last Dividend Paid | 0.6 |
About Embecta Corp Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Embecta Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Embecta Corp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Embecta Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Embecta Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Embecta Corp's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Embecta Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Embecta Corp Stock:Check out For information on how to trade Embecta Stock refer to our How to Trade Embecta Stock guide.You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Will Health Care Equipment & Supplies sector continue expanding? Could Embecta diversify its offerings? Factors like these will boost the valuation of Embecta Corp. Projected growth potential of Embecta fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Embecta Corp data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 0.827 | Dividend Share 0.6 | Earnings Share 1.69 | Revenue Per Share | Quarterly Revenue Growth (0.08) |
Embecta Corp's market price often diverges from its book value, the accounting figure shown on Embecta's balance sheet. Smart investors calculate Embecta Corp's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Embecta Corp's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Embecta Corp's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Embecta Corp should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Embecta Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.